ImmunoGen - Ownership and Business Overview

Life ScienceCompany

ImmunoGen Ownership

Who owns ImmunoGen?

ImmunoGen is owned by AbbVie. It was acquired on November 30, 2023.

Was ImmunoGen formerly PE-backed?

Yes. ImmunoGen was formerly owned by 1 private investor.

ImmunoGen Business Overview

Where is ImmunoGen headquartered?

ImmunoGen is headquartered in Waltham, Massachusetts.

What is ImmunoGen’s revenue?

ImmunoGen disclosed revenue of 109M USD for 2022 and 70M USD for 2021.

How many employees does ImmunoGen have?

ImmunoGen has 277 employees.

What sector is ImmunoGen in?

ImmunoGen is a life science company.

When was ImmunoGen founded?

ImmunoGen was founded in 1980.

Life Science M&A Summary in 2023

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2023. The largest life science acquisition in 2023 was Seagen - which was acquired by Pfizer for $43.0B.

Join Mergr to view all 201 acquisitions of life science companies in 2023, including 25 acquisitions by private equity firms, and 176 by strategics.

ImmunoGen

ImmunoGen, Inc.

830 Winter Street,
Waltham, Massachusetts 02451
United States,
(781) 895-0600
www.immunogen.com

ImmunoGen is a clinical-stage biotechnology company that develops targeted anticancer therapeutics using its proprietary ADC technology. ImmunoGen was founded in 1980 and is based in Waltham, Massachusetts.


 Subscribe to unlock this and 207,502
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.